Marktumfang und Geschäftsstatistiken für pharmazeutische Vertragsvertriebsorganisationen bis 2030
Pharmaceutical Contract Sales Organizations Market Report Scope
Berichtsattribut | Details |
---|---|
Marktgröße im Jahr 2022 | 8,21 Milliarden US-Dollar |
Marktgröße bis 2030 | 15,82 Milliarden US-Dollar |
Globale CAGR (2022 - 2030) | 8,6 % |
Historische Daten | 2020-2021 |
Prognosezeitraum | 2023–2030 |
Abgedeckte Segmente | Nach Services
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
Market Players Density: Understanding Its Impact on Business Dynamics
The Pharmaceutical Contract Sales Organizations Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Pharmaceutical Contract Sales Organizations Market are:
- CMIC Holdings Co., Ltd.
- Axxelus
- EPS Holdings, Inc.
- MaBico
- IQVIA, Inc.
Disclaimer
: The companies listed above are not ranked in any particular order.
- Get the Pharmaceutical Contract Sales Organizations Market top key players overview
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global pharmaceutical contract sales organizations market are listed below:
- In September 2022, IQVIA, Inc. collaborated with pharmaceutical company Dr. Reddy's Laboratories. As per the arrangement, IQVIA provided Dr. Reddy's access to its Orchestrated Customer Engagement (OCE) platform to assist with its CRM operations. According to the partnership, Dr. Reddy's provided IQVIA's OCE application to all of its marketing users and field staff in India so they could more effectively engage customers by integrating marketing, account management, medical scientific liaison, sales, and other activities.
- In July 2021, ICON plc—a global provider of outsourced drug and device development and commercialization services to the pharmaceutical, biotechnology, medical device, and government and public health firms—acquired PRA Health Sciences, Inc. The merger enhances the consulting, clinical, and commercial services portfolio, geographic presence, therapeutic capabilities, and data-powered healthcare technology of the ICON, which aims to provide internationally scaled expertise and solutions.
Competitive Landscape and Key Companies:
CMIC Holdings Co Ltd, Axxelus Inc, EPS Holdings Inc, MaBico SA, IQVIA Holdings Inc, Peak Pharma Solutions Inc, QFR Solutions LLC, Promoveo Health LLC, Syneos Health Inc und Mednext Pharmaceuticals Pvt Ltd gehören zu den führenden Pharma-Vertragsverkaufsorganisationen. Diese Unternehmen konzentrieren sich auf neue technologische Dienstleistungen, die Weiterentwicklung bestehender Dienstleistungen und geografische Expansionen, um der wachsenden Verbrauchernachfrage weltweit gerecht zu werden.